New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccinationFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Evaluating vaccination strategies for tuberculosis in endemic and non-endemic settingsFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Affordability of adult tuberculosis vaccination in India and China: A dynamic transmission model-based analysisFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
BCG and new preventive tuberculosis vaccines: Implications for healthcare workers.Friday, August 9, 2024Accessibility, Implementation strategies and feasibilityRead More
The health and economic benefits possible with novel tuberculosis vaccines – A modeling study in India and IndonesiaFriday, August 9, 2024Availability, Epidemiological impactRead More
Mixed vaccination strategy for the control of tuberculosis: A case study in ChinaFriday, August 9, 2024Availability, Epidemiological impactRead More
Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and IndiaFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?Friday, August 9, 2024Availability, Epidemiological impactRead More
Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.Friday, August 9, 2024Availability, Epidemiological impactRead More
